IFNα activates dormant haematopoietic stem cells in vivo
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Maintenance of the blood system is dependent on dormant haematopoietic stem cells (HSCs) with long-term self-renewal capacity. After injury these cells are induced to proliferate to quickly re-establish homeostasis. The signalling molecules promoting the exit of HSCs out of the dormant stage remain largely unknown. Here we show that in response to treatment of mice with interferon-alpha (IFNalpha), HSCs efficiently exit G(0) and enter an active cell cycle. HSCs respond to IFNalpha treatment by the increased phosphorylation of STAT1 and PKB/Akt (also known as AKT1), the expression of IFNalpha target genes, and the upregulation of stem cell antigen-1 (Sca-1, also known as LY6A). HSCs lacking the IFNalpha/beta receptor (IFNAR), STAT1 (ref. 3) or Sca-1 (ref. 4) are insensitive to IFNalpha stimulation, demonstrating that STAT1 and Sca-1 mediate IFNalpha-induced HSC proliferation. Although dormant HSCs are resistant to the anti-proliferative chemotherapeutic agent 5-fluoro-uracil, HSCs pre-treated (primed) with IFNalpha and thus induced to proliferate are efficiently eliminated by 5-fluoro-uracil exposure in vivo. Conversely, HSCs chronically activated by IFNalpha are functionally compromised and are rapidly out-competed by non-activatable Ifnar(-/-) cells in competitive repopulation assays. Whereas chronic activation of the IFNalpha pathway in HSCs impairs their function, acute IFNalpha treatment promotes the proliferation of dormant HSCs in vivo. These data may help to clarify the so far unexplained clinical effects of IFNalpha on leukaemic cells, and raise the possibility for new applications of type I interferons to target cancer stem cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic pro-inflammatory signaling due to chronic infections or repetitive sterile inflammation, however, has been shown to be detrimental to HSPC self-renewal, promoting loss of quiescence and differentiation [61–65].”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [63]
In the citing paper
“The isolated effects of individual inflammatory cytokines, including type 1 interferons (IFNa/b) 1-3 , type 2 IFN (IFNg) 4-6 , TNFa 7,8 , and IL-1 9-11 , have been well-documented in mouse hematopoietic development.”
From Type 1 interferon perturbates clonal competition by reshaping human blood development (2026) · cites this paper as [9]
In the citing paper
“multiple different sterile and infection-associated inflammatory stimuli have been shown to provoke primitive hematopoietic stem cells (HSCs) to exit their long-term quiescent state and enter into active proliferation”
From Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging (2022) · cites this paper as Essers et al., 2009
In the citing paper
“The sterile inflammation that it promotes results in a temporarily discrete hematologic response consisting of transient peripheral blood (PB) cytopenias and a parallel increase in proliferation of long-term HSCs (LT-HSCs), all of which return to homeostatic levels within 4 days”
From Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging (2022) · cites this paper as Essers et al., 2009
In the citing paper
“In addition to IL-6, other cytokines such as IFNα, IFNγ, IL-1α, IL-1β, and TNFα can also directly activate HSCs (Baldridge et al., 2010; Essers et al., 2009; Pietras et al., 2014; Pietras et al., 2016; Sujer, 2014).”
From Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis (2018) · cites this paper as Essers et al., 2009
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Kiel, M. J., Yilmaz, Ö. H., Iwashita, T., Yilmaz, O. H., Terhorst, C., & Morrison, S. J. (2005) · Cell · doi:10.1016/j.cell.2005.05.026 · Cited by 3,168
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Wilson, A., Laurenti, E., Oser, G., van der Wath, R. C., Blanco-Bose, W., Jaworski, M., Offner, S., Dunant, C. F., Eshkind, L., Bockamp, E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.048 · Cited by 1,908
Self-citationInducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Bone-marrow haematopoietic-stem-cell niches
Wilson, A., & Trumpp, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1779 · Cited by 1,354
Self-citationHematopoietic Stem Cell Quiescence Maintained by p21 cip1/waf1
Cheng, T., Rodrigues, N., Shen, H., Yang, Y.-G., Dombkowski, D., Sykes, M., & Scadden, D. T. (2000) · Science · doi:10.1126/science.287.5459.1804 · Cited by 1,339
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,242
Cited by
Items 401–500 of 1,002
Lack of the ubiquitin-editing enzyme A20 results in loss of hematopoietic stem cell quiescence
Nakagawa, M. M., Thummar, K., Mandelbaum, J., Pasqualucci, L., & Rathinam, C. V. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20132544 · Cited by 56
“Intriguingly, up-regulation of Sca1 in HSPCs has been connected with increased cell cycle activity (Essers et al., 2009).”
BackgroundResultInfluentialThe Source and Dynamics of Adult Hematopoiesis: Insights from Lineage Tracing
Pucella, J. N., Upadhaya, S., & Reizis, B. (2020) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-020520-114601 · Cited by 53
SETD1A protects HSCs from activation-induced functional decline in vivo
Arndt, K., Kranz, A., Fohgrub, J., Jolly, A., Bledau, A. S., Virgilio, M. D., Lesche, M., Dahl, A., Höfer, T., Stewart, A. F., et al. (2018) · Blood · doi:10.1182/blood-2017-09-806844 · Cited by 54
Meacham, C. E., Jeffery, E. C., Burgess, R. J., Sivakumar, C. D., Arora, M. A., Stanley, A. M., Colby, E. M., Crane, G. M., Zhao, Z., & Morrison, S. J. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00909-9 · Cited by 54
Nicolini, F. E., Étienne, G., Dubruille, V., Roy, L., Huguet, F., Legros, L., Giraudier, S., Coiteux, V., Guerci‐Bresler, A., Lenain, P., et al. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(14)00027-1 · Cited by 53
Bacterial c-di-GMP Affects Hematopoietic Stem/Progenitors and Their Niches through STING
Kobayashi, H., Kobayashi, C. I., Nakamura‐Ishizu, A., Karigane, D., Haeno, H., Yamamoto, K. N., Sato, T., Ohteki, T., Hayakawa, Y., Barber, G. N., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.066 · Cited by 55
Interferon-Stimulated Genes and Their Protein Products: What and How?
Borden, E. C., & Williams, B. R. G. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0129 · Cited by 53
CD86 is expressed on murine hematopoietic stem cells and denotes lymphopoietic potential
Shimazu, T., Iida, R., Zhang, Q., Welner, R. S., Medina, K. L., Alberola-lla, J., & Kincade, P. W. (2012) · Blood · doi:10.1182/blood-2011-10-388736 · Cited by 49
Guilhot, F., Druker, B. J., Larson, R. A., Gathmann, I., So, C., Waltzman, R. J., & O'Brien, S. G. (2009) · Haematologica · doi:10.3324/haematol.2009.010629 · Cited by 53
“, who demonstrated that IFN-α treatment stimulates dormant hematopoietic stem cells thereby making them susceptible to other chemotherapeutic agents.(14) The data discussed in this study focus on cytogenetic responses.”
BackgroundIL-27 receptor-regulated stress myelopoiesis drives abdominal aortic aneurysm development
Peshkova, I. O., Aghayev, T., Fatkhullina, A. R., Makhov, P. B., Titerina, E. K., Eguchi, S., Tan, Y. F., Kossenkov, A. V., Хорева, М. В., Gankovskaya, L. V., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13017-4 · Cited by 54
The Interactions Between Cancer Stem Cells and the Innate Interferon Signaling Pathway
Martín-Hijano, L., & Sáinz, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00526 · Cited by 57
“For example, regarding IFNs and dormancy, it is known that IFN-α is able to activate dormant hematopoietic stem cells (HSCs), inducing them to proliferate and making them more vulnerable to anti-cycling therapies such as 5-fluorouracil (194); however, while CSCs share many common features with normal stem cells, they…”
BackgroundGene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation
Ferrari, S., Vavassori, V., Canarutto, D., Jacob, A., Castiello, M. C., Omer, A., & Genovese, P. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.618378 · Cited by 57
“Activation of PRRs in HSPCs and overexpression of IFNstimulated genes (ISGs) can induce a variety of outcomes, including exit from quiescence, differentiation and apoptosis (Essers et al., 2009; Sato et al., 2009; Liu et al., 2012).”
BackgroundBone Marrow Immune Microenvironment in Myelodysplastic Syndromes
Kouroukli, O., Symeonidis, A. S., Foukas, P. G., Maragkou, M., & Kourea, E. P. (2022) · Cancers · doi:10.3390/cancers14225656 · Cited by 58
Interferon-α signaling promotes embryonic HSC maturation
Kim, P. G., Canver, M. C., Rhee, C., Ross, S. J., Harriss, J. V., Tu, H.-C., Orkin, S. H., Tucker, H. O., & Daley, G. Q. (2016) · Blood · doi:10.1182/blood-2016-01-689281 · Cited by 50
Haltalli, M. L. R., Watcham, S., Wilson, N. K., Eilers, K., Lipien, A., Ang, H., Birch, F., Anton, S. G., Pirillo, C., Ruivo, N., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-00601-w · Cited by 49
MODELING THE DYNAMICS OF CHRONIC MYELOGENOUS LEUKEMIA THROUGH FRACTIONAL-CALCULUS
Tang, T.-Q., Jan, R., Rehman, Z. U., Shah, Z., Vrînceanu, N., & Racheriu, M. (2022) · Fractals · doi:10.1142/s0218348x22402629 · Cited by 51
Role of Hippo Signaling in Cancer Stem Cells
Hao, J., Zhang, Y., Jing, D., Li, Y., Li, J., & Zhao, Z. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24455 · Cited by 55
“Third, similar to many normal stem cells, some CSCs have been reported to shift between quiescent, slow-cycling, and active states (Essers et al., 2009; Tian et al., 2011).”
BackgroundQuiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia
Lutz, C., Woll, P. S., Hall, G. W., Castor, A., Dreau, H. M.-P., Cazzaniga, G., Zuna, J., Jensen, C., Clark, S. A., Biondi, A., et al. (2012) · Leukemia · doi:10.1038/leu.2012.306 · Cited by 51
The interferon-dependent orchestration of innate and adaptive immunity after transplantation
Robb, R. J., & Hill, G. R. (2012) · Blood · doi:10.1182/blood-2012-02-368076 · Cited by 50
Kreutzman, A. S., Rohoň, P., Faber, E., Indrák, K., Juvonen, V., Kairisto, V., Voglová, J., Sinisalo, M., Flochová, E., Vakkila, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023022 · Cited by 52
“Recent studies have also suggested that it can promote the cycling of normal quiescent hematopoietic stem cells [22].”
BackgroundCell-autonomous regulation of hematopoietic stem cell cycling activity by ATP
Casati, A., Frascoli, M., Traggiai, E., Proietti, M., Schenk, U., & Grassi, F. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.107 · Cited by 55
Nakagawa, M. M., Chen, H. A., & Rathinam, C. V. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00143 · Cited by 52
“…of inflammatory cytokines in these immune cells and that inflammatory cytokines can directly influence the physiology of HSCs, including quiescence (Essers et al., 2009; Sato et al., 2009; Baldridge et al., 2010), it remains possible that the HSC phenotype of IKK2CAVavcre mice might be…”
BackgroundRatajczak, M. Z., & Kucia, M. (2021) · Leukemia · doi:10.1038/s41375-021-01482-0 · Cited by 51
Yan, H. H., Walker, F. C., Ali, A., Han, H., Tan, L., Veillon, L. J., Lorenzi, P. L., Baldridge, M. T., & King, K. Y. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021006816 · Cited by 54
Ageing, immune fitness and cancer
Dolan, M., Libby, K. A., Ringel, A. E., van Galen, P., & McAllister, S. S. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00858-z · Cited by 62
“Mouse studies further show that both IFNα and IFNγ drive dormant HSCs into the cell cycle 77,78 , and repeated HSC activation leads to functional attrition and accelerated ageing phenotypes, characterized by increased myeloid differentiation and reduced clonal diversity 79 (Fig.”
Finkielsztein, A., Schlinker, A. C., Zhang, L., Miller, W. M., & Datta, S. K. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.11.013 · Cited by 55
Proietti, E., Moschella, F., Capone, I., & Belardelli, F. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.11.005 · Cited by 51
“…proliferation of dormant hematopoietic stem cells (HSCs) in vivo, whereas chronic activation of the IFN-a pathway in HSCs impairs their function (Essers et al., 2009), it is possible to envisage that IFN-a, acutely induced by a single CTX administration, can mediate the proliferation of BM…”
BackgroundLu, X., Chen, Q., Rong, Y.-J., Yang, G., Li, C., Xu, N., Yu, C., Wang, H., Zhang, S., Shi, Y., et al. (2016) · Nature Communications · doi:10.1038/ncomms12719 · Cited by 52
Moro, M., Bertolini, G., Pastorino, U., Roz, L., & Sozzi, G. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000563 · Cited by 50
What's new on circulating tumor cells? A meeting report
Lianidou, E. S., Mavroudis, D., Sotiropoulou, G., Agelaki, S., & Pantel, K. (2010) · Breast Cancer Research · doi:10.1186/bcr2601 · Cited by 58
Rabe, J. L., Hernandez, G., Chavez, J. S., Mills, T. S., Nerlov, C., & Pietras, E. M. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2019.12.003 · Cited by 49
“reconstitution activity in Fgd5-mCherry+ SLAM cells from poly I:C-treated mice was essentially identical to control mice[48], whereas prior work had shown that unfractionated IFN-exposed SLAM cells exhibited impaired long-term reconstitution activity[19, 23].”
ResultLópez, D. A., Apostol, A. C., Lebish, E. J., Valencia, C. H., Romero-Mulero, M. C., Pavlovich, P. V., Hernandez, G. E., Forsberg, E. C., Cabezas‐Wallscheid, N., & Beaudin, A. E. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111677 · Cited by 51
Do we need more drugs for chronic myeloid leukemia?
Holyoake, T. L., & Helgason, G. V. (2014) · Immunological Reviews · doi:10.1111/imr.12234 · Cited by 53
Ross, D. M., & Hughes, T. P. (2014) · British Journal of Haematology · doi:10.1111/bjh.12892 · Cited by 50
“There are various hypotheses that might account for a beneficial effect of IFN, including its pleiotropic immunological effects and stem cell depletion (Essers et al, 2009).”
BackgroundMasamoto, Y., Arai, S., Sato, T., Kubota, N., Takamoto, I., Kadowaki, T., & Kurokawa, M. (2017) · Stem Cells · doi:10.1002/stem.2640 · Cited by 45
Impact of inflammation on early hematopoiesis and the microenvironment
Takizawa, H., & Manz, M. G. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2266-5 · Cited by 53
Lee, D., Shin, K.-J., Kim, D. W., Yoon, K., Choi, Y., Lee, B. N. R., & Cho, J. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0562-5 · Cited by 53
McRae, H. M., Garnham, A. L., Hu, Y., Witkowski, M. T., Corbett, M. A., Dixon, M. P., May, R. E., Sheikh, B. N., Chiang, W., Kueh, A. J., et al. (2019) · Blood · doi:10.1182/blood-2018-07-860726 · Cited by 54
Mitochondrial Contributions to Hematopoietic Stem Cell Aging
Morganti, C., & Ito, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011117 · Cited by 54
Unleashing Cell-Intrinsic Inflammation as a Strategy to Kill AML Blasts
Ellegast, J. M., Alexe, G., Hamze, A., Lin, S., Uckelmann, H. J., Rauch, P. J., Pimkin, M., Ross, L. S., Dharia, N. V., Robichaud, A. L., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0956 · Cited by 53
Maurer, B., Brandstoetter, T., Kollmann, S., Sexl, V., & Prchal‐Murphy, M. (2020) · Haematologica · doi:10.3324/haematol.2020.256313 · Cited by 54
Mechanisms involved in hematopoietic stem cell aging
Fujino, T., Asada, S., Goyama, S., & Kitamura, T. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04356-5 · Cited by 56
“interferon (IFN)-α [210], IFN-γ[211], lipopolysaccharide (LPS) [212, 213], and polyinosine-polycytidylic acid (pIpC) [210, 214, 215] produce transient proliferation and myeloidskewed differentiation of HSCs at the expense of lymphogenesis.”
BackgroundPlasmacytoid dendritic cells control homeostasis of megakaryopoiesis
Gaertner, F., Ishikawa-Ankerhold, H. C., Stutte, S., Fu, W., Weitz, J., Dueck, A., Nelakuditi, B., Fumagalli, V., van den Heuvel, D., Belz, L., et al. (2024) · Nature · doi:10.1038/s41586-024-07671-y · Cited by 48
“exhaustion of HSCs 28,44,45 .”
Hasselbalch, H. C. (2014) · Expert Review of Hematology · doi:10.1586/17474086.2013.876356 · Cited by 48
Cre-dependent DNA recombination activates a STING-dependent innate immune response
Pépin, G., Ferrand, J., Höning, K., Jayasekara, W. S. N., Cain, J. E., Behlke, M. A., Gough, D. J., G. Williams, B. R., Hornung, V., & Gantier, M. P. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw405 · Cited by 44
Proinflammatory Signals as Fuel for the Fire of Hematopoietic Stem Cell Emergence
Espín-Palazón, R., Weijts, B. G. M. W., Mulero, V., & Traver, D. J. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.08.003 · Cited by 51
Common Sources of Inflammation and Their Impact on Hematopoietic Stem Cell Biology
Hormaechea‐Agulla, D., Le, D. T., & King, K. Y. (2020) · Current Stem Cell Reports · doi:10.1007/s40778-020-00177-z · Cited by 50
Chronic viral infections persistently alter marrow stroma and impair hematopoietic stem cell fitness
Isringhausen, S., Mun, Y., Kovtonyuk, L. V., Kräutler, N. J., Suessbier, U., Gomariz, Á., Spaltro, G., Helbling, P. M., Wong, H. C., Nagasawa, T., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20192070 · Cited by 51
“In stark contrast, the quiescent fraction of HSPCs transplanted into LCMV-cl13–infected hosts was shown as percentage of HRPT expression (n = 3–5 samples from at least two independent experiments).”
BackgroundMethodInfluentialDevelopmental differences in IFN signaling affect GATA1s-induced megakaryocyte hyperproliferation
Woo, A. J., Wieland, K., Huang, H., Akie, T. E., Piers, T., Kim, J., & Cantor, A. B. (2013) · Journal of Clinical Investigation · doi:10.1172/jci40609 · Cited by 49
“demonstrated that IFN-α signaling activates dormant hematopoietic stem cells (31).”
Cortes, J. E., Quintás‐Cardama, A., Jones, D. M., Ravandi, F., Garcia‐Manero, G., Verstovšek, S., Koller, C. A., Hiteshew, J., Shan, J., O'Brien, S. M., et al. (2010) · Cancer · doi:10.1002/cncr.25438 · Cited by 47
Zhao, Y. L., Ling, F., Wang, H.-C., & Sun, X.-H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055552 · Cited by 52
“Although BrdU labeling used in the label-retaining assay has been thought to disturb the quiescence of HSC [37], data from examination of Ki67 levels in HSC by intracellular staining also suggested that LPS treatment directs the cells out of the G0 state.”
MethodWenk, C., Garz, A.-K., Grath, S., Huberle, C., Witham, D., Weickert, M., Malinverni, R., Niggemeyer, J., Kyncl, M. C., Hecker, J. S., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018022053 · Cited by 53
Sio, A., Chehal, M. K., Tsai, K., Fan, X., Roberts, M. E., Nelson, B. H., Grembecka, J. E., Cierpicki, T., Krebs, D. L., & Harder, K. W. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0842 · Cited by 55
“Notably, actively cycling HSCs and HSCs in inflammatory environments may be functionally defective (34, 35).”
BackgroundRegulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention
Tamamouna, V., Pavlou, E., Neophytou, C. M., Papageorgis, P., & Costeas, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213931 · Cited by 53
An In Vivo Functional Screen Uncovers miR-150-Mediated Regulation of Hematopoietic Injury Response
Adams, B. D., Guo, S., Bai, H., Guo, Y., Megyola, C. M., Cheng, J., Heydari, K., Xiao, C., Reddy, E. P., & Lü, J. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.014 · Cited by 46
“Note that we waited 35 days between the pIpC and 5-FU treatments to avoid an effect on stem cell activation (Essers et al., 2009).”
Lack of Trex1 Causes Systemic Autoimmunity despite the Presence of Antiretroviral Drugs
Achleitner, M., Kleefisch, M., Hennig, A., Peschke, K., Polikarpova, A., Oertel, R., Gabriel, B., Schulze, L., Lindeman, D., Gerbaulet, A., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700714 · Cited by 49
Nakagawa, M. M., & Rathinam, C. V. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.071 · Cited by 49
Palandri, F., Castagnetti, F., Iacobucci, I., Martinelli, G., Amabile, M., Gugliotta, G., Poerio, A., Testoni, N., Breccia, M., Bocchia, M., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.021246 · Cited by 46
CD48 on hematopoietic progenitors regulates stem cells and suppresses tumor formation
Boles, N. C., Lin, K., Lukov, G. L., Bowman, T. V., Baldridge, M. T., & Goodell, M. A. (2011) · Blood · doi:10.1182/blood-2010-12-322339 · Cited by 48
Influenza Virus Infection during Pregnancy as a Trigger of Acute and Chronic Complications
Oseghale, O., Vlahos, R., O’Leary, J. J., Brooks, R. D., Brooks, D. A., Liong, S., & Selemidis, S. (2022) · Viruses · doi:10.3390/v14122729 · Cited by 49
“NLRP3 inflammasomes can be activated by IAV, which involves an M2 ion channel and PB1-F2 response, together with increased activation of NF-κB, the secretion of IL1β and IL-18, plus increased oxidative stress, reduced autophagy and this leads to lung injury [29,30].”
BackgroundCell Fusion, Drug Resistance and Recurrence CSCs
Nagler, C., Zänker, K. S., & Dittmar, T. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0782-5_9 · Cited by 45
“Likewise, Interferon-α (IFN-α) has been shown to activate dormant hematopoietic stem cells in vivo, which might be an explanation for the so far unexplained positive clinical effects of IFN-α on leukemic cells [ 30 ].”
BackgroundOptineurin Regulates the Interferon Response in a Cell Cycle-Dependent Manner
Génin, P., Cuvelier, F., Lambin, S., Filipe, J. C.-R., Autrusseau, E., Laurent‐Winter, C., Laplantine, E., & Weil, R. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004877 · Cited by 51
Myeloproliferative Neoplasms: JAK2 Signaling Pathway as a Central Target for Therapy
Pasquier, F., Cabagnols, X., Secardin, L., Plo, I., & Vainchenker, W. (2014) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2014.06.014 · Cited by 51
Shami, P. J., & Deininger, M. W. (2011) · Leukemia · doi:10.1038/leu.2011.217 · Cited by 45
Origin and production of inflammatory perivascular macrophages in pulmonary hypertension
Florentin, J., & Dutta, P. (2017) · Cytokine · doi:10.1016/j.cyto.2017.08.015 · Cited by 48
Siedel, H., Roers, A., Rösen‐Wolff, A., & Luksch, H. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108466 · Cited by 47
Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia
Barreyro, L., Sampson, A. M., Ishikawa, C., Hueneman, K. M., Choi, K., Pujato, M. A., Chutipongtanate, S., Wyder, M. A., Haffey, W. D., O'Brien, E. J., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abb7695 · Cited by 50
IFNα-mediated remodeling of endothelial cells in the bone marrow niche
Prendergast, Á. M., Kuck, A., van Essen, M., Haas, S., Blaszkiewicz, S., & Essers, M. A. G. (2017) · Haematologica · doi:10.3324/haematol.2016.151209 · Cited by 41
Self-citationSuppression of luteinizing hormone enhances HSC recovery after hematopoietic injury
Velardi, E., Tsai, J. J., Radtke, S., Cooper, K., Argyropoulos, K. V., Jae-Hung, S., Young, L. F., Lazrak, A., Smith, O. M., Lieberman, S., et al. (2018) · Nature Medicine · doi:10.1038/nm.4470 · Cited by 42
Laustsen, A., Bak, R. O., Krapp, C., Kjær, L., Egedahl, J. H., Petersen, C. C., Pillai, S. K., Tang, H. Q., Uldbjerg, N., Porteus, M. H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05816-y · Cited by 49
Lee, G., Jeong, S., Lee, H., & Oh, I. (2019) · Scientific Reports · doi:10.1038/s41598-018-36999-5 · Cited by 57
Fioravanti, J., González, I., Medina‐Echeverz, J., Larrea, E., Ardaiz, N., González‐Aseguinolaza, G., Prìeto, J., & Berraondo, P. (2011) · Hepatology · doi:10.1002/hep.24306 · Cited by 44
Gerber-Ferder, Y., Cosgrove, J., Duperray-Susini, A., Missolo-Koussou, Y., Dubois, M., Stepaniuk, K., Pereira-Abrantes, M., Sedlik, C., Lameiras, S., Baulande, S., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01291-w · Cited by 50
Clapp, G. D., Lepoutre, T., Cheikh, R. E., Bernard, S., Ruby, J., Labussière‐Wallet, H., Nicolini, F. E., & Levy, D. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0611 · Cited by 43
“Additionally, IFN-α may drive quiescent leukemic stem cells into the cell cycle [9, 10], where they become exposed to the effects of TKIs.”
BackgroundMasárová, L., Yin, C. C., Cortes, J. E., Konopleva, M. Y., Borthakur, G. M., Newberry, K. J., Kantarjian, H. M., Bueso-Ramos, C., & Verstovšek, S. (2017) · Experimental Hematology and Oncology · doi:10.1186/s40164-017-0090-5 · Cited by 43
Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin
Hiller, B., Hoppe, A., Haase, C., Hiller, C., Schubert, N., Müller, W., Reijns, M. A. M., Jackson, A. P., Kunkel, T. A., Wenzel, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1099 · Cited by 45
Therapy resistance mechanisms in hematological malignancies
Hofmann, W., Trumpp, A., & Müller‐Tidow, C. (2022) · International Journal of Cancer · doi:10.1002/ijc.34243 · Cited by 44
Self-citationThe Role of Inflammation in the Initiation and Progression of Myeloid Neoplasms
Balandrán, J. C., Lasry, A., & Aifantis, I. (2023) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-22-0176 · Cited by 52
Du, C., Liu, C., Yu, K., Zhang, S., Fu, Z., Chen, X., Liao, W., Chen, J., Zhang, Y., Wang, X., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.07.009 · Cited by 50
Instruction of hematopoietic lineage choice by cytokine signaling
Endele, M., Etzrodt, M., & Schroeder, T. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.07.011 · Cited by 48
Do we have to kill the last CML cell?
Ross, D. M., Hughes, T. P., & Melo, J. V. (2010) · Leukemia · doi:10.1038/leu.2010.197 · Cited by 45
Ng, R. L. X., Scott, N. M., Strickland, D. H., Gorman, S., Grimbaldeston, M. A., Norval, M., Waithman, J., & Hart, P. H. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202786 · Cited by 41
Russ, A. C., Sander, S., Lück, S. C., Lang, K. M., Bauer, M., Rücker, F. G., Kestler, H. A., Schlenk, R. F., Döhner, H., Holzmann, K., et al. (2011) · Haematologica · doi:10.3324/haematol.2011.046888 · Cited by 42
Smith, J. N. P., Zhang, Y., Li, J. J., McCabe, A. F., Jo, H. J., Maloney, J., & MacNamara, K. C. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007234 · Cited by 46
Hematopoiesis under telomere attrition at the single-cell resolution
Thongon, N., Ma, F., Santoni, A., Marchesini, M., Fiorini, E., Rose, A. M., Ademà, V., Gañán‐Gómez, I., Groarke, E. M., Gutierrez‐Rodrigues, F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27206-7 · Cited by 41
Regulation of immune cell homeostasis by type I interferons
Mattei, F., Schiavoni, G., & Tough, D. F. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.05.002 · Cited by 44
Zhang, L., Tai, Y., Ho, M., Qiu, L., & Anderson, K. C. (2017) · Experimental Hematology and Oncology · doi:10.1186/s40164-017-0081-6 · Cited by 43
Maintenance of high-turnover tissues during and beyond homeostasis
Banjac, I., Maimets, M., & Jensen, K. B. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.03.008 · Cited by 44
Johnson, K. D., Conn, D. J., Shishkova, E., Katsumura, K. R., Liu, P., Shen, S., Ranheim, E. A., Kraus, S. G., Wang, W., Calvo, K. R., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191526 · Cited by 46
“Coordinating fate-promoting and -suppressing circuits to generate multipotency: Mechanistic considerations How does an enhancer deletion trigger progenitors to mount an ectopic innate immune response? IFN signaling is implicated in diverse HSPC functions in physiology and pathology (Baldridge et al., 2010; de Bruin et…”
BackgroundChen, L., & Ozato, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.621333 · Cited by 45
“It is reported that the injection of IFNa and Poly (I: C), a Type I IFN inducer, prompts LT- HSCs to exit quiescence prompting their proliferation (18).”
BackgroundType I Interferon-Mediated Regulation of Antiviral Capabilities of Neutrophils
Stegelmeier, A. A., Darzianiazizi, M., Hanada, K., Sharif, S., Wootton, S. K., Bridle, B. W., & Karimi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094726 · Cited by 44
IFN-α wakes up sleeping hematopoietic stem cells
Passegué, E., & Ernst, P. (2009) · Nature Medicine · doi:10.1038/nm0609-612 · Cited by 39
Buechler, M. B., Akilesh, H. M., & Hamerman, J. A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600813 · Cited by 42
The role of GATA2 in adult hematopoiesis and cell fate determination
Peters, I. J. A., de Pater, E., & Zhang, W. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1250827 · Cited by 45
Virant‐Klun, I., Štimpfel, M., Cvjetičanin, B., Bokal, E. V., & Skutella, T. (2013) · Journal of Ovarian Research · doi:10.1186/1757-2215-6-24 · Cited by 40
Treatment-free remission in patients with chronic myeloid leukemia
Réa, D., & Cayuela, J. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2295-0 · Cited by 43
A Chemoattractant-Guided Walk Through Lymphopoiesis
Lim, V., Zehentmeier, S., Fistonich, C., & Pereira, J. P. (2017) · Advances in immunology · doi:10.1016/bs.ai.2017.02.001 · Cited by 42
IFN Signaling in Inflammation and Viral Infections: New Insights from Fish Models
Langevin, C., Boudinot, P., & Collet, B. (2019) · Viruses · doi:10.3390/v11030302 · Cited by 44
Skov, V. (2020) · Cancers · doi:10.3390/cancers12082194 · Cited by 43
Mu, H., Zhu, X., Jia, H., Zhou, L., & Liu, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.643382 · Cited by 43
Metadata
- Authors
- Essers, M. A. G., Offner, S., Blanco-Bose, W. E., Waibler, Z., Kalinke, U., Duchosal, M. A., & Trumpp, A.
- Affiliations
- German Cancer Research Center (DE)
- École Polytechnique Fédérale de Lausanne (CH)
- Paul Ehrlich Institut (DE)
- Center for Experimental and Clinical Infection Research (DE)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Trumpp, Andreas
- Venue
- Nature
- Published
- 2009-02-11
- Volume
- 458
- Issue
- 7240
- Pages
- 904-908
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2011059916
- Cited by
- 1,368
- References
- 31
- Citations by year
- 2026: 59 · 2025: 72 · 2024: 67 · 2023: 96 · 2022: 91 · 2021: 99 · 2020: 90 · 2019: 72 · 2018: 68 · 2017: 81 · 2016: 82 · 2015: 60 · 2014: 99 · 2013: 80 · 2012: 71
- FWCI
- 56.02
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- hematopoietic stem cells, interferon-alpha, HSC proliferation, STAT1, Sca-1, IFNAR, type I interferon, 5-fluorouracil, leukemia, cancer stem cells, chemosensitization
- MeSH terms
- Animals, Antigens, Ly, Cell Count, Cell Cycle, Fluorouracil, Hematopoietic Stem Cells, Membrane Proteins, Mice, Inbred C57BL, Phosphorylation, Signal Transduction, Up-Regulation, Interferon-alpha, Cell Proliferation, STAT1 Transcription Factor, Mice, Receptor, Interferon alpha-beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.